GLP-1 Compounding Guide: FDA Updates and Conversation Tips Many pharmacists are finding themselves fielding more questions about compounded GLP1s lately, and the conversations can feel a bit overwhelming at times
We believe in an educational approach to help you transform unhealthy habits and create a renewed relationship with food to nourish your body and soul
More research is needed to study potential short- and long-term risks across a broader population, which is why GLP-1s are generally not recommended for breastfeeding women
However, compared with the liposomal form, they may be less effective in terms of absorption and bioavailability
Another peptide called PT-141, which is a metabolite of MT2, is already approved for therapy in women with hypoactive sexual desire disorder (HSDD) [14, 15]
"The Shot Heard 'Round the Pharmacy: FDA Takes Aim at GLP-1 Compounders." Longevity Lens